Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.80 |
| ▸ | HTT | P42858 | 2/20 | 0.80 |
| ▸ | PKM | P14618 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 8/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | HPGD | P15428 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.59 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.58 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.58 |
| ▸ | CRHBP | P24387 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2138516 | 1.00 | ALDH1A1 (0.80) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL8364474 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL22259791 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL3610679 | 0.87 | ALDH1A1 (0.67) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL3610678 | 0.87 | ALDH1A1 (0.67) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL15082797 | 0.87 | ALDH1A1 (0.67) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL31648510 | 0.86 | MAPT (0.82) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL30883296 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL22897308 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HTTPKMMAPTKMT2A | |
| SCHEMBL2270723 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HTTPKMMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10723998-B2 | Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells | NORTHEAST NORMAL UNIVERSITY (CN) | 2020-07-28 | — | — | US | claimed |
| EP-2242774-B2 | SELF-REPAIRING COMPOSITION, SELF-REPAIRING MATERIALS, SELF-REPAIRING METHODS AND APPLICATIONS | CATALYSE (FR) | 2018-09-26 | — | — | EP | claimed |
| US-20180195039-A1 | APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS | NORTHEAST NORMAL UNIVERSITY (CN) | 2018-07-12 | — | — | US | claimed |
| EP-2242774-B1 | SELF-REPAIRING COMPOSITION, SELF-REPAIRING MATERIALS, SELF-REPAIRING METHODS AND APPLICATIONS | CATALYSE (FR) | 2013-01-09 | — | — | EP | claimed |
| US-10723998-B2 | Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells | NORTHEAST NORMAL UNIVERSITY (CN) | 2020-07-28 | — | — | US | disclosed |
| US-20180195039-A1 | APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS | NORTHEAST NORMAL UNIVERSITY (CN) | 2018-07-12 | — | — | US | disclosed |
| US-9249237-B2 | Self-repairing composition, self-repairing materials, self-repairing methods and applications | CATALYSE (FR) | 2016-02-02 | — | — | US | disclosed |
| US-20120202912-A1 | SURFACE TREATMENT BY PHOTOPOLYMERISATION TO OBTAIN BIOCIDAL PROPERTIES | DESARROLLO DEL GRAFTING S.L. (ES) | 2012-08-09 | — | — | US | disclosed |
| US-20110057340-A1 | SELF-REPAIRING COMPOSITION, SELF-REPAIRING MATERIALS, SELF-REPAIRING METHODS AND APPLICATIONS | CATALYSE (FR) | 2011-03-10 | — | — | US | disclosed |
| US-20050095266-A1 | Surface treatment by photopolymerisation to obtain biocidal properties | DESARROLLO DEL GRAFTING S.L. (ES) | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195039-A1 | APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS | XPA, MEP1A, EED | ALDH1A1 107/4885HTT 3784/4885PKM 2068/4885 |
| US-10723998-B2 | Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells | XPA, MEP1A, EED | ALDH1A1 107/4885HTT 3784/4885PKM 2068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.